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1. Introduction 
Ornithine decarboxylase (EC 4.1.1.17) is thought 
to be the rate-limiting enzyme in the pathway for the 
synthesis of the polyamines, putrescine, spermidine 
and spermine, which are essential for cell prolifera- 
tion [ 1,2]. In the presence of inhibitors of protein or 
RNA synthesis, the activity of this enzyme decays 
with a half-life of 1 O-60 min [3-51, which has led 
to the conclusion that the sensitive response of this 
enzyme activity to growth conditions is associated 
with its high rate of synthesis and degradation. How- 
ever this instability has never been shown directly, 
e.g. by immunological precipitation techniques. 
There are many conflicting reports on the half-life of 
this enzyme and its variation in relation to changes 
in enzyme activity [3-91, suggesting a more involved 
mechanism for the regulation of this enzyme. Since 
the control of polyamine levels has been shown to 
be important in cystic fibrosis [8], cancerous growth 
[6,9,11], and chemotherapy [ 12,131, it is essential that 
the mode of regulation of this important enzyme be 
clarified. Here we lzport that the rapid decay in the 
ornithine decarboxylase activity of Physarum poly- 
cephalum [3] is associated with a reversible modifica- 
tion of the enzyme. Within 100 min of the inhibition 
of protein synthesis by cycloheximidc, the apparent 
Km of the pyridoxal-5’-phosphate (PLP) activation 
of this enzyme varied seven-fold, while the Km for 
the substrate, ornithine, was unchanged. We believe 
this modification, and not enzyme protein instability, 
is responsible for the rapid fluctuations in this 
enzyme’s activity associated with variations in cell 
growth. 
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2. Materials and methods 
Pyridoxal-5’-phosphate, L-ornithine and cyclo- 
heximide were purchased from Sigma Chemical Co. 
DL [ 1 -l 4 C] Ornithine . HC 1 (29 /+&i/mole) was 
obtained from Amersham/Searle Corporation. 
2.1. Culture techniques 
Cultures of P. polycephalum were maintained and 
samples extracted as described earlier [3]. 
2.2. Preparation of enzyme extracts 
Frozen tissue pellets containing about 3-5 mg of 
protein were suspended in 3 ml of 0.05 M borate 
buffer (pH 8.15), containing 0.5 mM dithiothreitol 
and 0.2 mM EDTA, disrupted by sonicating for 
30 set and assayed immediately. 
2.3. Ornithine decarboxylase activity 
Enzyme activity was determined by measuring 
the liberation of ’ 4 CO2 from DL- [ 1 -I4 C] ornithine 
as detailed earlier [3], except hyamine hydroxide 
was used to absorb the 14C02 which was counted in 
a toluene-based scintillation fluid. The incubation 
mixtures are described in the figure legends. 
3. Results 
3.1. Effects of cycloheximide on ornithine decarb- 
oxylase activity 
The inhibition of protein synthesis in P. poZy- 
cephalum by 25 pg/ml cycloheximide induces a very 
rapid loss in ornithine decarboxylase activity when 
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Fig. 1. Decay in ornithine decarboxylase activity in micro- 
plasmodia exposed to 25 &ml of cycloheximide. Inhibitor 
was added to a shake-flask culture of Physarum micro- 
plasmodia t time 0 and subsequently 3 ml samples were 
extracted, frozen and eventually assayed as described in 
Materials and methods. Assay mix contained 100 ~1 of 
enzyme extract and 1.9 ml of 0.05 M borate buffer 
(pH 8.15), 0.5 mM dithiothreitol, 0.2 mM EDTA, 0.05 mM 
L-ornithine (0.05 nCi), and 1 PM PLP. 
assayed as described in the legend to fig. 1. If the 
temporary increase in activity during the first few 
minutes of the cycloheximide inhibition is ignored, 
the apparent half-life calculated between 5 and 40 
min of treatment is about 18 min, comparable to the 
short half-lifes reported in mammalian tissues [4-91. 
3.2. Effect of cyloheximide on substrate stimulation 
of ornithine decarboxylase activity 
To investigate the possibility that an alteration in 
the enzyme’s ability to bind substrate may be partially 
responsible for the rapid variation in activity in 
response to cycloheximide, several of the above 
fractions were assayed for activity in various ornithine 
concentrations. The double reciprocal plots of these 
data (fig. 2) indicate that the apparent K, of 
ornithine activation is unaffected by the cyclo- 
heximide treatment, with an average value of 
0.27 mM. 
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Fig. 2. Substrate stimulation of ornithine decarboxylase 
during treatment with cycloheximide. The enzyme samples 
representing 0 (o-o-o), 5 (X-X-X), 20 (o-n-n), 
60 (A-A-A) and 100 (e-o-e) min exposure to cyclo- 
heximide of fig. 1 were assayed at varying omithine con- 
centrations, using 50 PM PLP in the assay mix and procedure 
outlined in fig. 1. Lines were drawn by a simple linear 
regression. 
3.3. Effect of cycloheximide on coenzyme stimula- 
tion of ornithine decarboxylase 
Since there is no detectible ornithine decarboxylase 
activity in crude enzyme preparations without added 
PLP [3], we also tested the ability of this coenzyme 
to stimulate activity as a possible indication of an 
altered enzyme state. Each of the nine enzyme 
fractions from the experiment illustrated in fig. 1 
was assayed for activity in the presence of varying 
concentrations of PLP. The double reciprocal plot of 
this data (fig. 3) illustrates the extreme variation in 
PLP binding ability resulting from the inhibition of 
protein synthesis. The apparent K, ‘s for PLP activa- 
tion were extrapolated from this data using a simple 
linear regression program, and plotted with respect 
to time in cycloheximide (fig. 4). This plot illustrates 
a sharp initial decrease and an eventual seven-fold 
increase in the K, of PLP activation. Since any 
change in this K, would cause an inverse variation 
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Fig. 3. Variation in the stimulation of ornithine decarboxylase activity by PLP during inhibition with cycloheximide. The enzyme 
samplesof fig. 1 at 0 (o-o-o), 5 (X-X-X), 10 (D--D-~), 20 (a-a-a), 30 (*-o-o), 40 (+-+-+), 60 (m-a-m), 80 (I-A-A) and 
100 (*-*-*) min were assayed at varying PLP concentrations using the techniques and basic assay mix described in the legend to 
fig. 1. Lines were drawn by a simple linear regression. 
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in activity assayed in coenzyme levels that are less 
saturating, it is obvious that this alteration in enzyme 
character is at least partially responsible for the rapid 
variations in enzyme activity noted in fig. 1. 
To illustrate the extent this enzyme alteration 
actually affected the pattern in fig. 1 the enzyme 
activity of each sample was calculated at saturating 
PLP concentrations using the extrapolated y-inter- 
cepts of fig, 3. When the logs of these maximum 
velocities are plotted against time (fig. 5) the 
characteristic pattern of a sharp activity increase and 
rapid decay is much less pronounced, although still 
obvious. An optically fitted exponential decay curve 
drawn from these points indicates a T1/2 of 70 min. 
Fig. 4. Changes in the Km of PLP activation of omithine 
decarboxylase activity during cycloheximide inhibition. The 
negative inverse of the extrapolated x-intercepts of fig. 3 
are plotted to express K, variation during cycloheximide 
treatment. 
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Fig. 5. Cycloheximide induced decrease in enzyme activity 
at saturating coenzyme levels. The inverse of the y-intercepts 
of the data of fig. 3, representing the extrapolated reaction 
velocities at saturating PLP concentrations, are plotted with 
respect to time on cycloheximide. The curve connecting 
data points (---) is seen to diverge from a logarithmic 
&cay curve (-) in a pattern similar to the more pronounced 
variations een at limiting PLP concentrations in fig. 1. 
considerably longer than the 18 min calculated from 
fig. 1. 
3.4. Stability of the enzyme alteration produced by 
cycloheximide inhibition 
To test the possibility that a small molecule may 
be present in the crude enzyme extract which 
inhibits the coenzyme activation of this enzyme, 
1 ml samples of the crude enzyme preparation from 
0 and 100 min after cycloheximide treatment were 
each dialyzed overnight against two changes of 
400 ml buffer at 4’C, and their PLP stimulation 
kinetics assayed as before. In each case the dialyzed 
sample had the same apparent PLP K, fractions were 
mixed and assayed to test for the presence of a 
soluble regulatory molecule in the crude enzyme 
extracts. In the PLP concentration range tested from 
0.5 to 10 PM, the activity of the mix did not deviate 
from that expected from the sum of the two enzyme 
sub-fractions. 
4. Discussion 
The results presented in this paper suggest a rapid 
modification in ornithine decarboxylase caused by 
the inhibition of protein synthesis. Since this modifi- 
cation involves a marked increase in the enzyme’s 
apparent K, for PLP, then assays performed at 
limiting PLP concentrations reflect these rapid 
enzyme alterations as apparent variations in the 
enzyme activity (fig. 1). Heretofore, possible varia- 
tions in the coenzyme stimulation of this enzyme 
have not been investigated, yet limiting coenzyme 
concentrations are indicated in the majority of assay 
procedures reported in the literature, because these 
involve either Tris buffer or great excesses of 
ornithine, both of which will readily form Schiff- 
bases with the coenzyme and lower its effective con- 
centrations [ 14,151. We believe, therefore, that it is 
basically this enzyme modification, and not the 
innate instability of the enzyme molecule, which is 
responsible for the pattern of rapid enzyme activity 
variations reported for this enzyme. 
If inhibition of protein synthesis merely modified 
the ability of ornithine decarboxylase to be activated 
by PLP, then assays in the presence of saturating 
levels of PLP would be unaffected by this modifica- 
tion and thus could be used to indicate the exponen- 
tial decay of this enzyme (half-life). The extra- 
polated enzyme velocities at saturating PLP levels 
(fig. S), however, deviate from the exponential 
decrease in activity predicted and they appear to lose 
activity in a pattern which resembles the inhibition 
due to the alteration in the K,,, for PLP. This suggests 
that the rapid change in ornithine decarboxylase 
activity following this inhibition of protein synthesis 
may result from an enzyme modification which 
affects both the turnover number, or efficiency, of 
the enzyme and its ability to bind the coenzyme. If 
this modification does affect both these enzyme 
functions, as is the case with some allosteric regulators, 
then the actual half-life of this enzyme is probably 
much longer than the 70 min calculated from fig. 5. 
Although this paper reports only on the enzyme 
modification in response to cycloheximide, we have 
found that similar modifica’tions may be induced by 
culture starvation and the inhibitors of RNA synthesis, 
cordycepin and actinomycin D. This would suggest 
that a small protein factor must be continually 
123 
Volume 49. number 1 FEBSLETTERS December 1974 
synthesized to maintain the optimal activity of the 
enzyme or else a negative regulatory molecule, such 
as the idling factor in bacteria, is produced when 
RNAs and proteins are not being synthesized. Such a 
regulatory molecule has already been implicated in 
the repressive nzyme modifications of bacterial 
ornithine decarboxylase [ 161. 
The stimulation of the enzyme activity during the 
first 5 min of cycloheximide treatment is due to an 
increased Vmax and a decreased K, for PLP, suggest- 
ing that the modification of this enzyme is reversible. 
Thus rapid increases in enzyme activity which 
accompany the stimulation of growth, may reflect 
the reversal of an inhibitory modification rather than 
the stimulation of new enzyme synthesis. Recent 
studies in our laboratory indicate that the PLP K,,, of 
this enzyme fluctuates over a 1 O-fold range in 
response to variations in developmental state or the 
phase of the mitotic cycle, indicating that this 
modification may be the natural mechanism for 
regulation of this critical enzyme pathway in the low 
PLP concentrations found in viva. 
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